I don't agree with the analysis either but I can see where she is coming from. I think a fair few people invested in MSB in the last 2-3 months based on COVID-19 results.
For me who invested in MSB prior to all this i kind of see it as a bonus but so much of the MSB forum is based on COVID-19 trial results and nothing else. Perhaps that's why there is a suggestion it's inflated a bit?
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-218
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |